NEW YORK, Nov. 6 – Lion Bioscience and ACE BioSciences have entered into a proteomics-based collaboration, the companies said on Tuesday.
Under the terms of the deal, Lion, based in Heidelberg, Germany, has licensed its SRS platform as well as its piSCOUT, bioSCOUT, and genomeSCOUT software to ACE.
In exchange, ACE, of Odense, Denmark, intends to generate protein-protein interaction data that will be put into a library to be connected to SCOUT and made available exclusively to the companies’ customers.
“Our main focus isn’t to generate data and we don’t want to compete with Incyte to set up databases, so this is the most efficient way for us to [expand] our products,“ said Lion spokeswoman Andrea Kreisselmeier.
Ace said that by using Lion’s software it would be able to link genomics data with proteomics data.
“With the integrated software solutions of Lion we can most efficiently link theoretical information from comparative genomics with the scientific data of the ‘real world’ experimental or functional proteomics results,” Angus King, chief scientific officer at ACE BioSciences, said in a statement.
The companies did not disclose the financial terms of the deal.